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Question: Does prophylactic use of noninvasive ventilation 
(NIV) before and after elective lobectomy affect post-
operative oxygenation, pulmonary function, atelectasis, and 
length of stay in hospital? Design: Randomised, controlled 
trial with concealed allocation and blinded assessment of 
some outcomes. Setting: Surgical unit of a tertiary hospital 
in France. Participants: Adults with lung cancer and lung 
function < 70% of the predicted value who were scheduled for 
elective lobectomy via posterolateral thoracotomy. Thirty-
nine patients were randomised one week preoperatively 
to a NIV group (n = 22) or a control group (n = 19). 
Interventions: Both groups received standard postoperative 
care, including at least four days in the surgical intensive 
care unit and epidural analgesia. In addition, the NIV group 
used bilevel positive airway pressure for five one-hour 
periods daily from seven days prior to surgery until three 
days after surgery. During an initial one-hour acclimatisation 
period, the inspiratory positive airway pressure (IPAP) was 
titrated up from 8cmH2O to the maximum tolerated, and 
the expiratory positive airway pressure (EPAP) was set at 
2 to 4cmH2O. Outcome measures: Arterial blood gases 
(pH, PaO2, PaCO2) and lung function (FEV1, FVC) were 
measured at enrolment, after the seven days of preoperative 
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Synopsis
NIV, two hours postoperatively, and daily until the third 
day after surgery. Chest radiographs performed two hours 
postoperatively and daily until the third day after surgery 
were assessed by radiologists for the presence of lobar 
atelectasis. The duration of hospital stay, opioid use, and pain 
and dyspnoea scores were also recorded. Results: Thirty-two 
participants completed the study. One patient in the control 
group required invasive ventilation for total pneumothorax 
immediately postoperatively and was excluded from the 
analysis. Six patients in the NIV group were excluded from 
the analysis because the surgical procedure was changed. 
Compared to the control group, arterial blood gases were 
significantly better in the NIV group after the seven days of 
pre-operative NIV and remained significantly better at all or 
most of the post-operative measurement points. Similarly, 
lung function was significantly better in the NIV group at 
most of the postoperative measurement points. Incidence 
of lobar atelectasis was not reduced significantly, with the 
number needed to treat to prevent one case of atelectasis 
estimated at 4 (95% CI –2 to 14). The duration of hospital 
admission was significantly reduced, by 7 (95% CI 5 to 
9) days. Opioid use did not significantly differ between 
the groups, while pain and dyspnoea scores were not 
reported. Conclusion: Prophylactic use of NIV pre- and 
postoperatively significantly reduces pulmonary dysfunction 
and length of hospital stay after elective lobectomy.
[NNT, 95% CIs, and statistical power calculated by the CAP 
Co-ordinator]
Commentary
Despite lung cancer being the fourth leading cause of cancer 
death in Australia (AIHW 2007), little research is available 
investigating interventions to improve outcomes following 
lung resection. The current study highlights improvements 
in short-term physiological outcomes and hospital length of 
stay (LOS) in thoracic surgical patients receiving both pre- 
and postoperative NIV.
Whilst the reported reduction in the LOS is clinically 
important, the management outlined in this study is not 
representative of practice in Australian tertiary hospitals. 
Most patients return directly to the ward postoperatively 
rather than spend four days in a surgical ICU. In addition 
the LOS in the control group of 19 ± 3 and intervention 
group of 12 ± 1 is higher than mean data reported in similar 
populations: Spain < 10 days (Varela et al 2006); New 
Zealand unpublished audit of 50 patients 7 ± 3 days.
Atelectasis can be associated with development of 
several pathophysiological effects including impairment 
in oxygenation. The study did not identify a statistically 
significant effect of NIV on the incidence of atelectasis, 
but statistical power for this outcome was low (calculated 
retrospectively at 33%). The confidence interval includes 
effect sizes that would be considered clinically worthwhile, 
so the effect on atelectasis could be investigated further.
Pre-rehabilitation is an emerging concept although few 
have studied NIV for this purpose. However, in the current 
study the more significant responses to NIV occurred in the 
postoperative period and these changes are consistent with 
those found in previous research (Auriant et al 2001).
Using international classification systems to categorise 
FEV1 would allow assessment of the response to NIV in 
relation to the severity of airway obstruction. The timing of 
measurement of FEV1 and FVC in relation to pain scores 
post-operatively would have been useful inclusions in the 
paper, as spirometry is effort dependent.
Despite these clinical reservations, this study raises the issue 
of prophylactic use of NIV in surgical populations.
Linda Denehy 
The University of Melbourne
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